There were 643 press releases posted in the last 24 hours and 184,800 in the last 365 days.

SEATTLE, UNITED STATES, UNITED STATES, December 9, 2021 /EINPresswire.com/ -- Overview:

Enteral feeding devices are used for delivering nutrients through a tube. These devices are used for feeding patient that cannot swallow the food. Enteral feeding is normally administered to geriatric and pediatric patients by nasogastric tube and gastrostomy or Percutaneous Endoscopic Gastroenteric (PEG) tube. Rising cases of cancer and other such chronic diseases are expected to support the growth of the enteral feeding devices market. Government agencies and some private agencies offer reimbursement for enteral feeding process including all feeding tubes that are used for feeding. 36 separate health insurance companies in the U.S. formed a federation, Blue Cross Blue Shield Association. All these companies offer insurance and medical coverage policy for treatment of enteral nutritrion in the U.S.

Global Enteral Feeding Devices Market, is estimated to be valued at US$ 3,260.6 million in 2020 and is expected to exhibit a CAGR of 5.8% over the forecast period (2021-2028).

Request for Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/392

BlueCHiP for Medicare and Commercial Products Coverage include enteral nutrition therapy, where nutrition is provided through nasoenteric (NE), nasogastric (NG), jejunostomy (J), or gastrostomy (G), feeding tube or via vein. Moreover, it covers parenteral or enteral formulas that needs prescription from a physician to use and administered at home.

In April 2020, the American Society for Parenteral and Enteral Nutrition (ASPEN) and the Society of Critical Care Medicine granted approval to regulations and recommendation for the nutrition delivery to patients with severe COVID-19 infection. The recommendations included; 1) Nutrition Assessment: Healthcare providers should follow the PPE (Personal Protective Equipment) standards provided by the CDC (Centers for Disease Control and Prevention) with COVID-19 patients.

2) Timing of Nutrition Delivery: after ICU admission, early enteral nutrition should start within 24 to 36 hours, and patients with high risk and for whom enteral nutrition is not feasible should be provided parenteral nutrition.

3) Route, Tube Placement and Method of Nutrition Delivery: Enteral nutrition should be prioritized before parenteral nutrition. Early use of parenteral nutrition is recommended for patients with gastrointestinal symptoms and after drop in the symptoms, enteral nutrition should be given to patients.

4) Nutrition Dose, Advancing to Goal, and Adjustments: In the first week of critical sickness, enteral nutrition should be administered in low dose (hypocaloric or trophic) and later it should be advanced to full dose.

5) Formula Selection: A standard high protein polymeric isosmotic enteral formula is recommended in the early severe phase of clinical illness.

6) Monitoring Nutrition Tolerance: Patients are recommended to be monitored through daily physical exam and confirmation of gas and stool passing, as in the early and late acute stages of critical illness, enteral feeding intolerance is commonly observed.

GET 25-30% Discount on Buying Whole Report

Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/392

Rising number of malnutrition cases are expected to boost growth of the global market of enteral feeding devices during the forecast period. For instance, as per the United Nations Children's Fund (UNICEF) report, the State of Palestine, Humanitarian Situation Report, January-June 2019, Gaza witnessed malnutrition in around 18% of pregnant women and 14% of lactating mothers, and only 14% of children under the age of 5 received minimum appropriate diet in 2019.

The global market of enteral feeding devices is expected to witness strong growth with CAGR of 5.8% during the forecast period due to rising cases of chronic diseases such as cancer. For instance, in 2019, as per the European Commission reports, cancer affected 1.4 million females and 1.6 million males. Feeding tube segment witnessed robust growth in 2020 due to rising prevalence of mental health and central nervous system diseases, which is expected to grow the feeding tubes demand.

Major players operating in the global enteral feeding devices market are Abbott Laboratories, Boston Scientific Corporation, Amsino International Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Moog, Inc., Dynarex Corporation, Cook Group, Cardinal Health, Inc., CONMED Corporation, Applied Medical Technology, Inc., Fresenius SE & Co. KGaA, Vygon S.A, and Medela AG.

Get Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/392

Global Enteral Feeding Devices Market, By Product Type:

Feeding Tubes Nasogastric Tube with ENFit Connector Orogastric Tube Nasoenteric Tube Nasojejunal Nasoduodenal Oroenteric Tube Gastrostomy Tube (G Tube) with ENFit Connector PEG (Percutenous Endoscopic Gastrostomy) Tube PRG (Percutaneous Radiologic Gastrostomy) Tube Button Tubes Jejunostomy Tubes PEJ (Percutaneous Endoscopic Jejunostomy) Tube PRJ (Percutaneous Radiologic Jejunostomy) Tube Feeding Pumps (Peristaltic Silicone) Administration Reservoir Extension Feeding Set With ENFit Connector Without ENFit Connector Enteral Syringes Others

Global Enteral Feeding Devices Market, By Age Group:

Global Enteral Feeding Devices Market, By Application:

Diabetes Oncology Gastrointestinal Diseases Hypermetabolism Others

Global Enteral Feeding Devices Market, By End User:

Hospitals Ambulatory Surgical Centers Others

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Mr. Shah Senior Client Partner – Business Development Coherent Market Insights Phone: US: +1-206-701-6702 UK: +44-020-8133-4027 Japan: +81-050-5539-1737 India: +91-848-285-0837 Email: sales@coherentmarketinsights.com Website: https://www.coherentmarketinsights.com

Mr.Shah Coherent Market Insights +1 2067016702 email us here

EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone's Internet News Presswire™, tries to define some of the boundaries that are reasonable in today's world. Please see our Editorial Guidelines for more information.

© 1995-2021 IPD Group, Inc. dba EIN Presswire All Right Reserved.